-

Acadia Healthcare Announces Date for Third Quarter 2026 Earnings Release

FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it will release its third quarter 2026 results on Wednesday, November 4, 2026, after the close of the market. Acadia will host a conference call with institutional investors and analysts on Thursday, November 5, 2026 at 9:00 a.m. ET. A live broadcast of the conference call will be available at www.acadiahealthcare.com in the “Investors” section of the website, and the archived webcast will be available after the call has ended.

About Acadia

Acadia is a leading provider of behavioral healthcare services across the United States (the “U.S.”). As of June 30, 2026, Acadia operated a network of 279 behavioral healthcare facilities with approximately 12,600 beds in 40 states and Puerto Rico. With approximately 25,000 employees serving more than 84,000 patients daily, Acadia is the largest stand-alone behavioral healthcare company in the U.S. Acadia provides behavioral healthcare services to its patients in a variety of settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers and outpatient clinics.

Description of Business

Unless the context otherwise requires, all references herein to “Acadia,” “the Company,” “we,” “us” or “our” mean Acadia Healthcare Company, Inc. and its consolidated subsidiaries. Acadia Healthcare Company, Inc. is a holding company whose direct and indirect subsidiaries own and operate acute inpatient psychiatric facilities, specialty treatment facilities, comprehensive treatment facilities, residential treatment facilities and facilities providing outpatient behavioral healthcare services to serve the behavioral healthcare and recovery needs of communities throughout the U.S. and Puerto Rico. The terms “facilities,” “centers,” “clinics,” and “hospitals” refer to entities owned, operated, or managed by subsidiaries of Acadia Healthcare Company, Inc. References herein to “employees” refer to employees of subsidiaries of Acadia Healthcare Company, Inc.

Contacts

Jason Plagman
Vice President, Investor Relations
InvestorRelations@acadiahealthcare.com

Acadia Healthcare Company, Inc.

NASDAQ:ACHC

Release Versions

Contacts

Jason Plagman
Vice President, Investor Relations
InvestorRelations@acadiahealthcare.com

More News From Acadia Healthcare Company, Inc.

Acadia Healthcare Announces Third Quarter 2026 Results and Raises Full Year 2026 Financial Guidance

FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) today announced financial results for the third quarter ended September 30, 2026. Third Quarter 2026 Results Revenue totaled $895.3 million, an increase of 5.1% compared with the third quarter of 2025 Same-facility revenue increased 5.2% compared with the third quarter of 2025, as patient days increased 1.1% and revenue per patient day increased 4.0% Net income attributable to Acadia tot...

Acadia Healthcare to Participate in November Investor Conferences

FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will participate in two investor conferences in November. On Monday, November 9, 2026, the Company will participate in the 2026 UBS Global Healthcare Conference. The Company’s presentation will begin at 11:00 a.m. Eastern Time/10:00 a.m. Central Time. On Wednesday, November 18, 2026, the Company will participate in the 2026 Stephens Annual Investment Conference. The Company’s presen...

Acadia Healthcare Provides Notice of Proposed Derivative Action Settlement

FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) issues the below summary notice of proposed settlement as provided for in the September 1, 2026 order providing preliminary approval issued by the United States District Court for the Middle District of Tennessee. UNITED STATES DISTRICT COURT MIDDLE DISTRICT OF TENNESSEE NASHVILLE DIVISION IN RE ACADIA HEALTHCARE COMPANY, INC. STOCKHOLDER DERIVATIVE LITIGATION Lead Case No. 3:19-cv-00167...
Back to Newsroom